Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.30 |
| ▸ | CA2 | P00918 | 4/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL2370865 | 1.00 | — | — | |
| Acetonitrile SCHEMBL1148960 | 1.00 | — | — | |
| Acetonitrile SCHEMBL7928496 | 0.94 | TSHR (0.31) | TSHRALDH1A1 | |
| Acetonitrile SCHEMBL11344691 | 0.94 | — | — | |
| Acetonitrile SCHEMBL1330624 | 0.93 | — | — | |
| Acetonitrile SCHEMBL10523138 | 0.93 | — | — | |
| Acetonitrile SCHEMBL6693864 | 0.93 | — | — | |
| Acetonitrile SCHEMBL1330705 | 0.93 | — | — | |
| Acetonitrile SCHEMBL10524251 | 0.93 | TSHR (0.36) | TSHRALDH1A1CA1CA2CA5A | |
| Acetonitrile SCHEMBL10051948 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746714-A1 | ANTIMICROBIAL COMPOSITIONS INCLUDING COPPER(I) SALTS AND ADDITIVES | Corning Incorporated (US) | 2026-05-27 | — | — | EP | claimed |
| CN-119569642-A | Method for directly decarboxylating and iodizing alkyl carboxylic acid by photo-oxidation reduction/copper co-catalysis | 天津科技大学 | 2025-03-07 | — | — | CN | claimed |
| WO-2025027140-A1 | N-ALKOXYAMINE MARKER AND PROCESSES | FMC Agricultural Solutions A/S (DK) | 2025-02-06 | — | — | WO | claimed |
| WO-2025019153-A1 | ANTIMICROBIAL COMPOSITIONS INCLUDING COPPER(I) SALTS AND ADDITIVES | CORNING INCORPORATED (US) | 2025-01-23 | — | — | WO | claimed |
| CN-119306745-A | Copper nanocluster, preparation method and application thereof, hydrogenation catalyst and preparation method of 4-formylmorpholine | 中国石油化工股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| US-12063933-B1 | Antimicrobial compositions including copper(I) salts and additives | CORNING INCORPORATED (US) | 2024-08-20 | — | — | US | claimed |
| CN-118307485-A | Preparation method of diazabicyclononane and decane | 五邑大学 | 2024-07-09 | — | — | CN | claimed |
| CN-115572335-B | Chitosan-based fluorescent probe for formaldehyde monitoring and preparation method and application thereof | 齐鲁工业大学 | 2024-01-16 | — | — | CN | claimed |
| CN-116332963-A | Copper (I) coordination compound and preparation method and application thereof | 苏州大学 | 2023-06-27 | — | — | CN | claimed |
| CN-116178432-A | Novel preparation method of fosfomycin sodium | 鼎元(天津)生物医药科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-20040204412-A1 | Phenylglycine derivatives useful as serine protease inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-14 | — | — | US | claimed |
| WO-2004072101-A2 | PHENYLGLYCINE DERIVATIVES USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-08-26 | — | — | WO | claimed |
| EP-0713513-A4 | TRIS(ISONITRILE)COPPER(I) SULFATES FOR PREPARING RADIONUCLIDE COMPLEXES | DU PONT MERCK PHARMA (US) | 1999-05-19 | — | — | EP | claimed |
| EP-0713513-A1 | TRIS(ISONITRILE)COPPER(I) SULFATES FOR PREPARING RADIONUCLIDE COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-05-29 | — | — | EP | claimed |
| WO-1995004114-A1 | TRIS(ISONITRILE)COPPER(I) SULFATES FOR PREPARING RADIONUCLIDE COMPLEXES | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-02-09 | — | — | WO | claimed |
| EP-0395695-B1 | TRIS(ISONITRILE)COPPER(I) ADDUCTS FOR PREPARING RADIONUCLIDE COMPLEXES | DU PONT MERCK PHARMA (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0395695-A4 | TRIS(ISONITRILE)COPPER(I) ADDUCTS FOR PREPARING RADIONUCLIDE COMPLEXES | — | 1991-04-17 | — | — | EP | claimed |
| US-5008418-A | Reacting cuprous acetonitrile complex or halide in solvent with isonitrile complex or ligand, desolventizing | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-04-16 | — | — | US | claimed |
| EP-0395695-A1 | TRIS(ISONITRILE)COPPER(I) ADDUCTS FOR PREPARING RADIONUCLIDE COMPLEXES. | DU PONT (US) | 1990-11-07 | — | — | EP | claimed |
| WO-1989002433-A1 | TRIS(ISONITRILE)COPPER(I) ADDUCTS FOR PREPARING RADIONUCLIDE COMPLEXES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204412-A1 | Phenylglycine derivatives useful as serine protease inhibitors | F7, SERPINE1, HABP2 | TSHR 1647/4885ALDH1A1 3767/4885CA1 2220/4885 |
| US-12063933-B1 | Antimicrobial compositions including copper(I) salts and additives | SOD1, AOC1, SOD3 | TSHR 4375/4885ALDH1A1 309/4885CA1 1992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.